NARROW MARGIN

Clinical trials for NARROW MARGIN explained in plain language.

Never miss a new study

Get alerted when new NARROW MARGIN trials appear

Sign up with your email to follow new studies for NARROW MARGIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to stop liver cancer from coming back

Disease control Recruiting now

This study tests whether combining radiation with an immunotherapy drug (sintilimab) works better than a standard procedure (TACE) to keep liver cancer from returning after surgery. It includes 286 adults whose tumors were removed but had narrow margins and high-risk features. Th…

Matched conditions: NARROW MARGIN

Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

NARROW MARGIN

Get alerted when new NARROW MARGIN trials appear

New combo therapy aims to stop liver cancer from coming back